Robert C Sergott1. 1. Department of Ophthalmology, Neurology, and Neurosurgery, Thomas Jefferson University, Wills Eye Hospital, Philadelphia, Pennsylvania 19107, USA. rcs220@comcast.net
Abstract
PURPOSE OF REVIEW: This review considers the latest developments in the use of optical coherence tomography in neuro-ophthalmology. RECENT FINDINGS: Optical coherence tomography can accurately and reproducibly quantitate the micron thickness of the peripapillary retinal nerve fiber layer, as well as the thickness and volume of the macula. It is able to perform both cross-sectional and longitudinal studies in patients with multiple sclerosis and optic neuritis. It is able to measure and assess axonal preservation and protection when used in clinical trials. SUMMARY: Specific guidelines when undertaking optical coherence tomography analyses for patients with multiple sclerosis and optic neuritis are needed to ensure uniformity among clinical trials; this development would be similar to the parameters devised when magnetic resonance imaging emerged as an important technology.
PURPOSE OF REVIEW: This review considers the latest developments in the use of optical coherence tomography in neuro-ophthalmology. RECENT FINDINGS: Optical coherence tomography can accurately and reproducibly quantitate the micron thickness of the peripapillary retinal nerve fiber layer, as well as the thickness and volume of the macula. It is able to perform both cross-sectional and longitudinal studies in patients with multiple sclerosis and optic neuritis. It is able to measure and assess axonal preservation and protection when used in clinical trials. SUMMARY: Specific guidelines when undertaking optical coherence tomography analyses for patients with multiple sclerosis and optic neuritis are needed to ensure uniformity among clinical trials; this development would be similar to the parameters devised when magnetic resonance imaging emerged as an important technology.
Authors: Zane S Schnurman; Teresa C Frohman; Shin C Beh; Darrel Conger; Amy Conger; Shiv Saidha; Steven Galetta; Peter A Calabresi; Ari J Green; Laura J Balcer; Elliot M Frohman Journal: Neurology Date: 2014-04-30 Impact factor: 9.910
Authors: John L Keltner; Kimberly E Cello; Laura J Balcer; Peter A Calabresi; Clyde E Markowitz; John S Werner Journal: Neuroophthalmology Date: 2011-03-20
Authors: Venu Talla; Vittorio Porciatti; Vince Chiodo; Sanford L Boye; William W Hauswirth; John Guy Journal: Invest Ophthalmol Vis Sci Date: 2014-07-11 Impact factor: 4.799
Authors: Alexander Klistorner; H Arvind; T Nguyen; R Garrick; M Paine; S Graham; J O'Day; C Yiannikas Journal: Doc Ophthalmol Date: 2008-09-09 Impact factor: 2.379
Authors: Han Cheng; Michal Laron; Jade S Schiffman; Rosa A Tang; Laura J Frishman Journal: Invest Ophthalmol Vis Sci Date: 2007-12 Impact factor: 4.799
Authors: Elena Garcia-Martin; Laura Jarauta; Elisa Vilades; Jose Ramon Ara; Jesus Martin; Vicente Polo; Jose Manuel Larrosa; Luis Emilio Pablo; Maria Satue Journal: J Ophthalmol Date: 2018-11-13 Impact factor: 1.909